Cargando…

Multiple primary lung cancer: Updates of clinical management and genomic features

In recent decades, multiple primary lung cancer (MPLC) has been increasingly prevalent in clinical practice. However, many details about MPLC have not been completely settled, such as understanding the driving force, clinical management, pathological mechanisms, and genomic architectures of this dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, He, Bai, Guangyu, Yang, Zhenlin, Chen, Ping, Xu, Jiachen, Liu, Tiejun, Fan, Tao, Wang, Bingning, Xiao, Chu, Li, Chunxiang, Gao, Shugeng, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993658/ https://www.ncbi.nlm.nih.gov/pubmed/36910635 http://dx.doi.org/10.3389/fonc.2023.1034752

Ejemplares similares

Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis
por: Tian, He, et al.
Publicado: (2023)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma
por: Zhao, Liang, et al.
Publicado: (2022)

PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinoma
por: Yang, Zhenlin, et al.
Publicado: (2022)

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
por: Yang, Zhenlin, et al.
Publicado: (2021)

Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2022)

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
por: Peng, Yue, et al.
Publicado: (2022)

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022)

A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes
por: Liu, Yu, et al.
Publicado: (2021)

Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations
por: Qu, Rirong, et al.
Publicado: (2022)

Treatments and whole exon sequencing of a case with multiple primary lung cancer
por: Bai, Guangyu, et al.
Publicado: (2023)

Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer
por: Li, Chunxiang, et al.
Publicado: (2021)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer
por: Yang, Zhenlin, et al.
Publicado: (2021)

Correlation between gene mutation status and clinicopathologic features in early multiple primary lung cancer
por: Teng, Fei, et al.
Publicado: (2023)

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

Knowledge mapping visualization of the pulmonary ground-glass opacity published in the web of science
por: Li, Xingchen, et al.
Publicado: (2022)

Exosome-Derived LncRNAs in Lung Cancer
por: Fan, Tao, et al.
Publicado: (2020)

RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Tiejun, et al.
Publicado: (2022)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
por: Zhang, Zhirong, et al.
Publicado: (2016)

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients
por: Tian, Yanhua, et al.
Publicado: (2020)

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Yu, et al.
Publicado: (2020)

Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma
por: Zhao, Xin-yu, et al.
Publicado: (2022)

Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care
por: Seesaghur, Anouchka, et al.
Publicado: (2021)

Preliminary study on the molecular features of mutation in multiple primary oral cancer by whole exome sequencing
por: Li, Kan, et al.
Publicado: (2022)

Primary Cutaneous B-Cell Lymphomas: An Update
por: Vitiello, Paola, et al.
Publicado: (2020)

Updates in the management of unknown primary of the head and neck
por: Kalavacherla, Sandhya, et al.
Publicado: (2022)

Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China
por: Han, Xiaoyan, et al.
Publicado: (2021)

Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma
por: He, Huayu, et al.
Publicado: (2021)

Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China
por: Han, Xiaoyan, et al.
Publicado: (2021)

Sarcopenia as a prognostic indicator in colorectal cancer: an updated meta-analysis
por: He, Jie, et al.
Publicado: (2023)

The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer
por: Wang, Juhong, et al.
Publicado: (2022)

Risk factors for bone metastasis in patients with primary lung cancer: study protocol for a systematic review
por: Niu, Yu-Jie, et al.
Publicado: (2014)

Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma
por: Yang, Xueying, et al.
Publicado: (2019)

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer
por: Li, Huanhuan, et al.
Publicado: (2021)

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
por: Fan, Tao, et al.
Publicado: (2021)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2021)

Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis
por: Wang, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_upvsc6gk4k8m4kj79vnntpngkk